LT3562935T - Trimatis in vitro alveolinis plaučių modelis, ir jo naudojimas nustatant ir (arba) prognozuojant įkvėpiamųjų produktų sensibilizuojančius poveikius - Google Patents
Trimatis in vitro alveolinis plaučių modelis, ir jo naudojimas nustatant ir (arba) prognozuojant įkvėpiamųjų produktų sensibilizuojančius poveikiusInfo
- Publication number
- LT3562935T LT3562935T LTEPPCT/EP2017/084583T LT17084583T LT3562935T LT 3562935 T LT3562935 T LT 3562935T LT 17084583 T LT17084583 T LT 17084583T LT 3562935 T LT3562935 T LT 3562935T
- Authority
- LT
- Lithuania
- Prior art keywords
- inhalated
- forecasting
- identifying
- dimensional
- products
- Prior art date
Links
- 238000000338 in vitro Methods 0.000 title 1
- 210000004072 lung Anatomy 0.000 title 1
- 230000001235 sensitizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
- C12N2502/1114—T cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
- C12N2502/1121—Dendritic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
- C12N2502/1157—Monocytes, macrophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/27—Lung cells, respiratory tract cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/04—Screening or testing on artificial tissues
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU93401A LU93401B1 (en) | 2016-12-27 | 2016-12-27 | Three-dimensional in vitro lung model, process for preparing said model, and its use for determining and/or predicting the sensitizing effects of inhalable products |
| PCT/EP2017/084583 WO2018122219A1 (en) | 2016-12-27 | 2017-12-26 | Three-dimensional in vitro alveolar lung model, process for preparing said model, and its use for determining and/or predicting the sensitizing effects of inhalable products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3562935T true LT3562935T (lt) | 2022-01-25 |
Family
ID=57629611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2017/084583T LT3562935T (lt) | 2016-12-27 | 2017-12-26 | Trimatis in vitro alveolinis plaučių modelis, ir jo naudojimas nustatant ir (arba) prognozuojant įkvėpiamųjų produktų sensibilizuojančius poveikius |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11566233B2 (lt) |
| EP (1) | EP3562935B8 (lt) |
| JP (1) | JP6934533B2 (lt) |
| KR (1) | KR102185041B1 (lt) |
| CN (1) | CN110168075B (lt) |
| AU (1) | AU2017385595B2 (lt) |
| BR (1) | BR112019013143A2 (lt) |
| CA (1) | CA3046351A1 (lt) |
| DK (1) | DK3562935T3 (lt) |
| ES (1) | ES2901618T3 (lt) |
| HR (1) | HRP20212005T1 (lt) |
| HU (1) | HUE056706T2 (lt) |
| IL (1) | IL267633B2 (lt) |
| LT (1) | LT3562935T (lt) |
| LU (1) | LU93401B1 (lt) |
| PL (1) | PL3562935T3 (lt) |
| PT (1) | PT3562935T (lt) |
| SI (1) | SI3562935T1 (lt) |
| WO (1) | WO2018122219A1 (lt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020141204A2 (en) * | 2019-01-03 | 2020-07-09 | Senzagen Ab | Analytical methods and arrays for use in the same |
| JPWO2021193700A1 (lt) * | 2020-03-25 | 2021-09-30 | ||
| GB202005154D0 (en) | 2020-04-07 | 2020-05-20 | Univ Of Hertfordshire Higher Education Corporation | Method and model |
| JP7799306B2 (ja) * | 2020-10-27 | 2026-01-15 | 学校法人東京医科大学 | 被検物質の感作性検出方法、感作抑制物質のスクリーニング方法、および生体投与用組成物の製造方法 |
| LU501055B1 (en) | 2021-12-21 | 2023-06-21 | Luxembourg Inst Science & Tech List | Aerosol deposition device |
| LU501054B1 (en) | 2021-12-21 | 2023-06-21 | Luxembourg Inst Science & Tech List | Aerosol deposition device |
| DE102022120500B3 (de) | 2022-08-15 | 2023-10-12 | FILK Freiberg Institute gGmbH | Verfahren und Vorrichtung zur Herstellung von Hohlkugeln aus Kollagen und Kollagenderivaten und Hohlkugeln aus Kollagen und Gelatine |
| LU503396B1 (en) | 2023-01-27 | 2024-07-29 | Luxembourg Inst Science & Tech List | Aerosol deposition device |
| EP4638693A1 (en) | 2022-12-23 | 2025-10-29 | Luxembourg Institute Of Science And Technology (List) | Aerosol deposition device |
| CN117363560A (zh) * | 2023-10-10 | 2024-01-09 | 安徽理工大学第一附属医院 | 一种煤尘纳米颗粒暴露致肺损伤体外细胞模型及其构建方法和应用 |
| LU507930B1 (en) | 2024-08-05 | 2026-02-05 | Luxembourg Institute Of Science And Tech | Serum-free culture medium for the culture of human monocytic cells and method using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009048661A1 (en) * | 2007-07-16 | 2009-04-16 | Vaxdesign Corporation | Artificial tissue constructs comprising alveolar cells and methods for using the same |
| CN103060266A (zh) * | 2012-12-14 | 2013-04-24 | 广州呼吸疾病研究所 | 人肺泡ii型上皮细胞的分离培养方法 |
| WO2015005349A1 (ja) * | 2013-07-09 | 2015-01-15 | 国立大学法人東京大学 | 細胞培養支持体、細胞培養装置、細胞培養キット、及び細胞シート |
-
2016
- 2016-12-27 LU LU93401A patent/LU93401B1/en active IP Right Grant
-
2017
- 2017-12-26 PT PT178287603T patent/PT3562935T/pt unknown
- 2017-12-26 JP JP2019555728A patent/JP6934533B2/ja active Active
- 2017-12-26 PL PL17828760T patent/PL3562935T3/pl unknown
- 2017-12-26 ES ES17828760T patent/ES2901618T3/es active Active
- 2017-12-26 WO PCT/EP2017/084583 patent/WO2018122219A1/en not_active Ceased
- 2017-12-26 CN CN201780081184.0A patent/CN110168075B/zh active Active
- 2017-12-26 AU AU2017385595A patent/AU2017385595B2/en not_active Ceased
- 2017-12-26 EP EP17828760.3A patent/EP3562935B8/en active Active
- 2017-12-26 US US16/472,335 patent/US11566233B2/en active Active
- 2017-12-26 HU HUE17828760A patent/HUE056706T2/hu unknown
- 2017-12-26 SI SI201731028T patent/SI3562935T1/sl unknown
- 2017-12-26 LT LTEPPCT/EP2017/084583T patent/LT3562935T/lt unknown
- 2017-12-26 KR KR1020197021488A patent/KR102185041B1/ko active Active
- 2017-12-26 DK DK17828760.3T patent/DK3562935T3/da active
- 2017-12-26 IL IL267633A patent/IL267633B2/en unknown
- 2017-12-26 HR HRP20212005TT patent/HRP20212005T1/hr unknown
- 2017-12-26 BR BR112019013143-4A patent/BR112019013143A2/pt active Search and Examination
- 2017-12-26 CA CA3046351A patent/CA3046351A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018122219A1 (en) | 2018-07-05 |
| AU2017385595A1 (en) | 2019-07-04 |
| AU2017385595B2 (en) | 2024-03-14 |
| PT3562935T (pt) | 2021-12-09 |
| CN110168075A (zh) | 2019-08-23 |
| LU93401B1 (en) | 2018-07-24 |
| RU2019119427A (ru) | 2021-01-29 |
| KR20190096415A (ko) | 2019-08-19 |
| EP3562935A1 (en) | 2019-11-06 |
| EP3562935B8 (en) | 2021-12-29 |
| HUE056706T2 (hu) | 2022-03-28 |
| HRP20212005T1 (hr) | 2022-04-01 |
| CN110168075B (zh) | 2024-01-05 |
| US11566233B2 (en) | 2023-01-31 |
| IL267633B2 (en) | 2023-11-01 |
| US20190376048A1 (en) | 2019-12-12 |
| SI3562935T1 (sl) | 2022-04-29 |
| IL267633B1 (en) | 2023-07-01 |
| RU2019119427A3 (lt) | 2021-02-04 |
| BR112019013143A2 (pt) | 2019-12-10 |
| ES2901618T3 (es) | 2022-03-23 |
| KR102185041B1 (ko) | 2020-12-02 |
| PL3562935T3 (pl) | 2022-02-07 |
| JP2020503892A (ja) | 2020-02-06 |
| JP6934533B2 (ja) | 2021-09-15 |
| CA3046351A1 (en) | 2018-07-05 |
| IL267633A (en) | 2019-08-29 |
| EP3562935B1 (en) | 2021-10-06 |
| DK3562935T3 (da) | 2021-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3562935T (lt) | Trimatis in vitro alveolinis plaučių modelis, ir jo naudojimas nustatant ir (arba) prognozuojant įkvėpiamųjų produktų sensibilizuojančius poveikius | |
| IL262092A (en) | Humanized anti-pacap antibodies and uses thereof | |
| IL251821A0 (en) | Cannabis extracts and methods of preparing and using same | |
| HUE040696T2 (hu) | Hidroxialkil-szubsztituált feniltriazol-származékok és alkalmazásuk | |
| SI3258951T1 (sl) | Anti-pvrig protitelesa in metode uporabe | |
| HUE053908T2 (hu) | Amid-szubsztituált piridiniltriazol-származékok és alkalmazásuk | |
| HUE052771T2 (hu) | C10orf54 elleni antitestek és alkalmazásuk | |
| SI3328419T1 (sl) | PD-1-vezavne molekule in postopki uporabe le-teh | |
| SI3116909T1 (sl) | Molekule protiteles na LAG-3 in njih uporaba | |
| IL242610A0 (en) | History of pyrazolopyrrolidine and their use in the treatment of diseases | |
| SI3394065T1 (sl) | Tetrahidropiranil amino-pirolopirimidinon in postopki za uporabo le-tega | |
| LT3532499T (lt) | Antikūnai prieš il-33 ir jų panaudojimas | |
| KR20180084867A (ko) | 음향 프리프레그, 코어 및 복합 물품 및 이의 사용 방법 | |
| LT2970303T (lt) | Pakeistieji ksantinai ir jų panaudojimo metodai | |
| DK3152296T3 (da) | Human hepatisk 3d-samkulturmodel og anvendelser deraf | |
| HRP20211272T8 (hr) | 24-hidroksisteroli supstituirani na poziciji 11 za uporabu u liječenju stanja povezanih sa nmda | |
| HUE039858T2 (hu) | 2,6-Szubsztituált purinszármazékok és alkalmazásuk proliferatív rendellenességek kezelésében | |
| SI3290441T1 (sl) | RGMA-vezavni protein in njegova uporaba | |
| LT3064498T (lt) | Pirazolpirimidono arba piroltriazono dariniai, jų paruošimo būdas ir jų farmacinis panaudojimas | |
| SI3102185T1 (sl) | Nanosuspenzija naravnih materialov in postopek priprave le-te | |
| HUE063621T2 (hu) | ß-interferon elleni ellenanyagok és alkalmazásuk | |
| HUE052074T2 (hu) | Mutáns VIII-as faktor készítmények és módszerek | |
| DK3166945T3 (da) | Hidtil ukendte triazolopyrimidinon- eller triazolopyridinderivater og anvendelse deraf | |
| LT3512849T (lt) | 7-pakeistieji 1-aril-naftiridin-3-karboksamidai ir jų naudojimas | |
| HUE045192T2 (hu) | 6-morfolinil-2-pirazolil-9H-purin származékok és felhasználásuk PI3K inhibitorokként |